200670 — Humedix Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual income statement for Humedix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	110,992	123,173	152,274	161,873	170,053
Cost of Revenue
Gross Profit	44,166	54,643	70,354	75,004	79,517
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	97,164	89,325	114,964	118,732	126,616
Operating Profit	13,828	33,848	37,310	43,141	43,437
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	11,339	28,989	32,410	48,355	63,818
Provision for Income Taxes
Net Income After Taxes	10,051	21,154	24,821	39,259	51,786
Minority Interest
Net Income Before Extraordinary Items
Net Income	9,065	21,086	24,821	39,259	51,786
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9,065	21,086	24,821	39,259	51,786
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,166	1,691	2,509	3,785	4,944
Dividends per Share